New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
January 25, 2024 - Zydus launched AB-rated generic versions of Almatica’s Gralise (gabapentin) 300 mg and 600 mg tablets.
Download PDF
Return to publications
